pulmonary arterial hypertension

White RJ, El-Kersh K, Rosenkranz S, Franco V, Vizza CD, Badagliacca R, Pepke-Zaba J, Elwing J, Argula RG, Shapiro S, Kim H, Seaman S, Shen[...]

By sjmartinez • December 3, 2024

Chin KM, Channick R, Kim NH, Ong R, Turricchia S, Martin N, Mitchell L, McLaughlin VV. Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart[...]

By sjmartinez • November 26, 2024

Flynn S, Chen H, Kerbel R, Gupta S, Jasuja S, Saggar R, Channick R, Sherman A. Management and outcomes in pulmonary arterial hypertension patients with[...]

By sjmartinez • October 29, 2024

Chin KM, Channick R, Kim NH, MacDonald G, Ong R, Martin N, Senatore A, McLaughlin VV. Macitentan and Tadalafil Combination Therapy in Incident and Prevalent[...]

By sjmartinez • September 25, 2024

Hong J, Medzikovic L, Sun W, Wong B, Ruffenach G, Rhodes CJ, Brownstein A, Liang LL, Aryan L, Li M, Vadgama A, Kurt Z, Schwantes-An[...]

By sjmartinez • August 22, 2024

Hoeper MM, Ewert R, Jansa P, Sirenko Y, Skride A, Balagtas C, Hackley S, Vogt S, Abreu P, Haughie S, Hassan T, Oudiz RJ. Randomized,[...]

By sjmartinez • May 16, 2024

Tang B, Vadgama A, Redmann B, Hong J. Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics. Respir Res. 2024 May 3;25(1):192. doi:[...]

By sjmartinez • May 5, 2024

Channick R, Chin KM, McLaughlin VV, Lammi MR, Zamanian RT, Turricchia S, Ong R, Mitchell L, Kim NH. Macitentan in Pulmonary Arterial Hypertension Associated with[...]

By sjmartinez • March 8, 2024

Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov[...]

By sjmartinez • February 19, 2024

Torbicki A, Channick R, Galiè N, Kiely DG, Moceri P, Peacock A, Swift AJ, Tawakol A, Vonk Noordegraaf A, Flores D, Martin N, Rosenkranz S.[...]

By sjmartinez • January 29, 2024